Risk-Window Palbociclib Exposure Delays ErbB2-Driven Mammary Tumorigenesis and Suppresses Mammary Epithelial Cell Stemness
Yongxuan Liu, Amanda B. Parris, Zhikun Ma, Limin Wei, Yijun Qi, Xiaohe Yang
Short-term palbociclib exposure during a premalignant risk window delays ErbB2-driven mammary tumorigenesis by suppressing stemness and proliferation.
bioRxiv · Sep 17, 2026 · PreprintCancer Biology